Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
20.16
-1.12 (-5.26%)
Apr 10, 2026, 1:10 PM EDT - Market open
Zenas BioPharma Market Cap
Zenas BioPharma has a market cap or net worth of $1.2 billion as of April 10, 2026. Its market cap has increased by 214.93% in one year.
Market Cap
1.20B
Enterprise Value
863.91M
1-Year Change
214.93%
Ranking
Category
Stock Price
$20.16
Market Cap Chart
Since the IPO on September 13, 2024, Zenas BioPharma's market cap has increased from $676.47M to $1.20B, an increase of 77.28%. That is a compound annual growth rate of 44.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 1.27B | -35.05% |
| Dec 31, 2025 | 1.95B | 469.46% |
| Dec 31, 2024 | 342.27M | -49.40% |
| Sep 13, 2024 | 676.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novavax | 1.37B |
| AtaiBeckley | 1.37B |
| Monte Rosa Therapeutics | 1.37B |
| Olema Pharmaceuticals | 1.37B |
| Wave Life Sciences | 1.34B |
| MoonLake Immunotherapeutics | 1.33B |
| Taysha Gene Therapies | 1.31B |
| Corvus Pharmaceuticals | 1.25B |